Internal Medicine, Gastroenterology · Baltimore, MD
NPI
1114009263
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
7505 Osler Dr, Suite 502
Baltimore, MD, 21204
Phone (410) 296-4210
Groups this clinician bills Medicare through
Medicare paid, 2024
$204K
1,552 services
Medicare patients, 2024
1,058
Average age 74
Drug cost, 2024
$786K
4,413 prescriptions
Company payments, 2025
$2,172
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aminur R Khan was code 45380 (lower gi endoscopy - other), 357 times for 357 patients. In total Aminur R Khan billed 1,552 services in 42 codes, and Medicare paid $204K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 357 | 357 | $155.47 | $56K |
| 43239 Upper GI Endoscopy | Facility | 300 | 294 | $87.22 | $26K |
| 99204 Office E&M - New | Office | 152 | 152 | $130.71 | $20K |
| 99214 Office E&M - Established | Office | 152 | 144 | $101.76 | $15K |
| 99213 Office E&M - Established | Office | 150 | 118 | $70.74 | $11K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 132 | 132 | $197.73 | $26K |
| 45385 Colonoscopy - Lesion Removal | Facility | 82 | 81 | $226.24 | $19K |
| 45378 Lower GI Endoscopy - Other | Facility | 47 | 47 | $150.32 | $7,065 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 41 | 41 | $200.36 | $8,215 |
| 43235 Upper GI Endoscopy | Facility | 30 | 29 | $94.48 | $2,834 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $114.30 | $2,057 |
| 45381 Lower GI Endoscopy - Other | Facility | 12 | 12 | $13.72 | $165 |
By year: 2022 $205K for 1,752 services; 2023 $202K for 1,658 services; 2024 $204K for 1,552 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aminur R Khan prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,171 prescriptions and refills. In total Aminur R Khan wrote 4,413 Medicare prescriptions that cost $786K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,171 | 2,041 | 401 | $19K |
| Famotidine Generic | 820 | 2,192 | 333 | $12K |
| Omeprazole Generic | 182 | 307 | 50 | $2,756 |
| Linzess Linaclotide | 167 | 289 | 54 | $150K |
| Cholestyramine Cholestyramine (With Sugar) | 150 | 309 | 60 | $15K |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 142 | 142 | 140 | $17K |
| Sucralfate Generic | 139 | 221 | 49 | $9,392 |
| Amitriptyline Hcl Generic | 106 | 303 | 39 | $1,039 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 100 | 100 | 99 | $6,391 |
| Rabeprazole Sodium Generic | 97 | 182 | 36 | $3,504 |
| Colestipol Hcl Generic | 95 | 146 | 35 | $5,427 |
| Dicyclomine Hcl Generic | 91 | 101 | 44 | $710 |
| Esomeprazole Magnesium Generic | 85 | 122 | 21 | $2,195 |
| Metoclopramide Hcl Generic | 85 | 85 | 56 | $290 |
| Mesalamine Generic | 64 | 130 | 21 | $32K |
Brand drugs: - claims; generic drugs: 3,736 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aminur R Khan $2,172 ($2,172 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $439.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $439 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $202 |
| Phathom Pharmaceuticals, Inc. PHAT | 9 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $195 |
| Janssen Biotech, Inc. JNJ | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $161 |
| Pfizer Inc. PFE | 7 | $139 |
| Amgen Inc. AMGN | 6 | $111 |
| Genzyme Corporation SNY | 4 | $102 |
| Madrigal Pharmaceuticals MDGL | 3 | $90.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.